SNV4818
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SNV4818, covering 2026-03-13 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: SNV4818 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]